IL158893A0 - Method for preparing human immunolobulin concentrates for therapeutic use - Google Patents

Method for preparing human immunolobulin concentrates for therapeutic use

Info

Publication number
IL158893A0
IL158893A0 IL15889302A IL15889302A IL158893A0 IL 158893 A0 IL158893 A0 IL 158893A0 IL 15889302 A IL15889302 A IL 15889302A IL 15889302 A IL15889302 A IL 15889302A IL 158893 A0 IL158893 A0 IL 158893A0
Authority
IL
Israel
Prior art keywords
therapeutic use
immunolobulin
concentrates
preparing human
preparing
Prior art date
Application number
IL15889302A
Other languages
English (en)
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Publication of IL158893A0 publication Critical patent/IL158893A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL15889302A 2001-05-11 2002-04-24 Method for preparing human immunolobulin concentrates for therapeutic use IL158893A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0106234A FR2824568B1 (fr) 2001-05-11 2001-05-11 Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
PCT/FR2002/001407 WO2002092632A1 (fr) 2001-05-11 2002-04-24 Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique

Publications (1)

Publication Number Publication Date
IL158893A0 true IL158893A0 (en) 2004-05-12

Family

ID=8863163

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15889302A IL158893A0 (en) 2001-05-11 2002-04-24 Method for preparing human immunolobulin concentrates for therapeutic use
IL158893A IL158893A (en) 2001-05-11 2003-11-16 Method for preparing human immunolobulin concentrates for therapeutic use, involving chromatography on an anion exchange at an alkaline ph

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158893A IL158893A (en) 2001-05-11 2003-11-16 Method for preparing human immunolobulin concentrates for therapeutic use, involving chromatography on an anion exchange at an alkaline ph

Country Status (11)

Country Link
US (1) US7186410B2 (da)
EP (1) EP1385886B1 (da)
JP (1) JP4445202B2 (da)
AT (1) ATE312120T1 (da)
CA (1) CA2446704C (da)
DE (1) DE60207848T2 (da)
DK (1) DK1385886T3 (da)
ES (1) ES2254676T3 (da)
FR (1) FR2824568B1 (da)
IL (2) IL158893A0 (da)
WO (1) WO2002092632A1 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
WO2007106617A2 (en) * 2006-01-30 2007-09-20 Talecris Biotherapeutics, Inc. Method of treatment and prophylaxis of diseases related to amyloid deposition using igm
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
FR2899112B1 (fr) 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines et de fragments f (ab)'2 et/ou fab specifiques d'un arbovirus en tant que medicament.
US7794721B2 (en) * 2006-12-13 2010-09-14 Simon Michael R Synthesis of human secretory IgM and the treatment of clostridium difficile associated diseases herewith
US7597891B2 (en) * 2006-12-13 2009-10-06 Simon Michael R Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
US8119104B2 (en) * 2006-12-13 2012-02-21 Michael R. Simon Treatment of celiac disease with IgA
FR2939667B1 (fr) 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
FR2940617B1 (fr) 2008-12-30 2012-04-20 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobulines g
MX2011012576A (es) 2009-05-27 2012-05-08 Baxter Int Metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo.
FR2949195B1 (fr) 2009-08-24 2011-10-14 Lfb Biomedicaments Poche de stockage de solution therapeutique
US8304248B2 (en) 2009-11-16 2012-11-06 Torres Anthony R Protein separation via ion-exchange chromatography and associated methods, systems, and devices
FR2952826B1 (fr) 2009-11-20 2012-04-06 Lab Francais Du Fractionnement Utilisation d'immunoglobulines polyvalentes pour traiter une cirrhose hepatique alcoolique ou metabolique
IT1397061B1 (it) 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
FR2961107B1 (fr) 2010-06-15 2012-07-27 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines stabilisee
FR2962650B1 (fr) * 2010-07-19 2013-04-05 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines concentrees
FR2974301B1 (fr) 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
FR2977893B1 (fr) * 2011-07-11 2015-02-20 Lab Francais Du Fractionnement Procede de preparation d'un concentre d'immunoglobulines polyvalentes
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
DK2820042T3 (da) 2012-02-29 2019-10-28 Baxalta GmbH Igg-stimuleret remyelinisering af perifere nerver
ES2751976T3 (es) 2012-03-09 2020-04-02 Csl Behring Ag Composiciones que comprenden inmunoglobulinas de tipo secretor
EP2636681A1 (en) * 2012-03-09 2013-09-11 CSL Behring AG Process for enriching IgA
EP2636684A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Prevention of infection
JP2016509068A (ja) * 2013-02-28 2016-03-24 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ クロマチン欠損細胞培養採取物からの抗体のクロマトグラフィー精製
EP3395423B1 (en) 2013-03-14 2023-09-20 Amgen Inc. Removal of leaked affinity purification ligand
CN105263946A (zh) * 2013-06-04 2016-01-20 新加坡科技研究局 蛋白质纯化方法
MX384222B (es) 2013-07-05 2025-03-14 Lab Francais Du Fractionnement Matriz de cromatografia de afinidad.
FR3018450B1 (fr) 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
FR3035971A1 (fr) 2015-05-07 2016-11-11 Lab Francais Du Fractionnement Composition enrichie en immunoglobulines polyclonales anti-a et/ou anti-b
CN105126100B (zh) * 2015-09-23 2021-01-26 成都蓉生药业有限责任公司 一种富含IgM的人免疫球蛋白制剂及其制备方法
EP3275897A1 (en) * 2016-07-27 2018-01-31 Biotest AG Process for preparing immunoglobulin compositions
FR3064485A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Traitement d'une infection par le virus respiratoire syncytial
FR3064484A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Composition d'immunoglobulines utiles pour traiter des infections virales
FR3064486A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Prevention d'une infection par le virus respiratoire syncytial dans les voies respiratoires superieures
CN108101981B (zh) * 2018-01-15 2019-06-04 四川远大蜀阳药业有限责任公司 一种静注免疫球蛋白的生产工艺
FR3081328B1 (fr) 2018-05-24 2021-01-01 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines concentrees
EP4126930A1 (en) 2020-03-31 2023-02-08 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation from c-1 inhibitor depleted plasma
WO2025068923A2 (en) 2023-09-26 2025-04-03 Takeda Pharmaceutical Company Limited IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305870A (en) * 1979-01-31 1981-12-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Intravenous plasma derivatives and their production
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
DE3927112C1 (da) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
DE59009020D1 (de) * 1990-03-22 1995-06-08 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates.
US5258177A (en) * 1991-12-10 1993-11-02 Alpha Therapeutic Corporation IgA preparation and process of making the same
FR2706466B1 (fr) * 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6150507A (en) * 1995-03-23 2000-11-21 Biopure Corporation Method for producing a purified hemoglobin product
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
JP4359352B2 (ja) * 1997-10-23 2009-11-04 田辺三菱製薬株式会社 室温保存製剤
NZ509135A (en) 1998-06-09 2002-10-25 Statens Seruminstitut A third generation intravenous immunoglobulin G (IVIG) purified using column chromatographic ion exchange methods

Also Published As

Publication number Publication date
DE60207848T2 (de) 2006-08-17
FR2824568B1 (fr) 2004-04-09
EP1385886A1 (fr) 2004-02-04
US20040132979A1 (en) 2004-07-08
ES2254676T3 (es) 2006-06-16
CA2446704A1 (fr) 2002-11-21
FR2824568A1 (fr) 2002-11-15
ATE312120T1 (de) 2005-12-15
AU2002257887A2 (en) 2002-11-25
DK1385886T3 (da) 2006-04-18
US7186410B2 (en) 2007-03-06
IL158893A (en) 2009-08-03
CA2446704C (fr) 2013-09-24
JP4445202B2 (ja) 2010-04-07
WO2002092632A1 (fr) 2002-11-21
EP1385886B1 (fr) 2005-12-07
JP2005500265A (ja) 2005-01-06
DE60207848D1 (de) 2006-01-12

Similar Documents

Publication Publication Date Title
IL158893A0 (en) Method for preparing human immunolobulin concentrates for therapeutic use
MY118591A (en) Improved methods for processing activated protein c
AU2002350205A1 (en) Apparatus, system and method for configuration of adaptive integrated circuitry having fixed, application specific computational elements
IL145337A0 (en) Process for partitioning of proteins
IL157446A0 (en) Increased recovery of active proteins
AU2002320041A1 (en) Method and system for treatment segmentation
EP1348961A4 (en) PROTEIN CHIPS, METHOD OF MANUFACTURING THEREOF, AND PROBLEM SYSTEM FOR PROTEIN CHIPS AND OPERATING PROCESS FOR THE SEALING SYSTEM
NO993424D0 (no) Fremgangsmåte til selektiv nedbrytning av melkeprotein i naervaer av andre melkeproteiner
AU2001265210A1 (en) Method and system for providing an online collections services marketplace
AU2001257274A1 (en) A method of treating soy proteins and a soy protein product produced by this method
UA27997C2 (uk) Агент екстракції периплазматичного рекомбінантного білка, спосіб одержання периплазматичного рекомбінантного білка (варіанти), спосіб культивування прокаріотичного мікроорганізму
AU4876196A (en) A process for the preparation of factor ix from biological sources
AU2002211115A1 (en) Process for recovering proteins from whey protein containing feedstocks
AU2002338765A1 (en) Method and system for processing fault hypotheses
AU2003226309A1 (en) System and method for conducting transactions without human intervention using speech recognition technology
EP1385993B8 (en) Method of detecting and treating tuberous sclerosis complex associated disorders
AUPM885294A0 (en) Chemically assisted protein annealing treatment
AU5641396A (en) A process for producing an undenatured whey protein concentrate
AU2002359310A1 (en) Treating diseases mediated by metalloprotease-shed proteins
NZ332323A (en) Chromatographic method for removing unconventional transmissible agents from a protein solution
AU2003282553A1 (en) Processor and method for processing vliw instructions
AU6477096A (en) Method of solubilizing, purifying, and refolding protein
MX9603369A (es) Aisalmiento de lactoferrina a partir de leche.
WO1997012969A3 (de) Fmr1-verwandtes protein
AU2001243404A1 (en) Methods, systems, and kits for the extracorporeal processing of blood